Stay updated on KZR-616 in SLE: Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in SLE: Clinical Trial page.

Latest updates to the KZR-616 in SLE: Clinical Trial page
- Check2 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the KZR-616 study, including its study design, eligibility criteria, locations, and results, instead of a 403 Forbidden message.SummaryDifference77%

- Check9 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA notice appears above the page announcing NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating the page is blocked from access. The new content includes a standard 403 page layout with a minimal header, a Home link, and a site footer.SummaryDifference20%

Stay in the know with updates to KZR-616 in SLE: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in SLE: Clinical Trial page.